Table 1.
Validation set patient characteristics
| Cholestatic controls (n=24) | Biliary atresia (n=24) | |
|---|---|---|
| Gender, male/female | 16/8 | 12/12 |
| Age at collection, days | 51.00 ± 4.12 | 55.75 ± 3.33 |
| Total bilirubin, mg/dL | 8.51 ± 0.56 | 8.28 ± 0.46 |
| Direct bilirubin, mg/dL | 5.32 ± 0.38 | 5.08 ± 0.35 |
| AST, IU/L | 165.54 ± 21.47 | 180.55 ± 16.52 |
| ALT, IU/L | 118.13 ± 15.26 | 122.79 ± 13.34 |
| Albumin, g/dL | 3.40 ± 0.09 | 3.62 ± 0.10 |
| Total protein, g/dL | 5.60 ± 0.11 | 6.07 ± 0.13 * |
| GGTP, U/L | 243.24 ± 70.38 | 571.33 ± 72.97 * |
| INR | 0.98 ± 0.02 | 1.32 ± 0.34 |
| PTT, seconds | 32.11 ± 0.96 | 39.24 ± 5.91 |
| Hemoglobin, g/dL | 10.73 ± 0.46 | 10.82 ± 0.30 |
| WBCs, 1000/mcl | 10.93 ± 0.93 | 12.86 ± 0.67 |
| Birth weight, kg | 3.85 ± 0.18 | 4.25 ± 0.14 |
AST=aspartate aminotransferase; ALT=alanine aminotransferase; GGTP=γ-glutamyl transpeptidase; INR=international normalized ratio; PTT=partial thromboplastin time; WBCs=white blood cells.
*
P<0.05.